verapamil hydrochloride

Generic: verapamil hydrochloride

Labeler: aphena pharma solutions - tennessee, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name verapamil hydrochloride
Generic Name verapamil hydrochloride
Labeler aphena pharma solutions - tennessee, llc
Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
Routes
ORAL
Active Ingredients

verapamil hydrochloride 240 mg/1

Manufacturer
Aphena Pharma Solutions - Tennessee, LLC

Identifiers & Regulatory

Product NDC 71610-268
Product ID 71610-268_5dfba728-4417-4a75-b194-87feff97aa7b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA078906
Listing Expiration 2026-12-31
Marketing Start 2009-09-17

Pharmacologic Class

Classes
calcium channel antagonists [moa] calcium channel blocker [epc] cytochrome p450 3a inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] p-glycoprotein inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 71610268
Hyphenated Format 71610-268

Supplemental Identifiers

RxCUI
897649
UNII
V3888OEY5R

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name verapamil hydrochloride (source: ndc)
Generic Name verapamil hydrochloride (source: ndc)
Application Number ANDA078906 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 240 mg/1
source: ndc
Packaging
  • 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-268-60)
source: ndc

Packages (1)

71610-268-60 90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-268-60)

Ingredients (1)

verapamil hydrochloride (240 mg/1)

Linked Drug Pages (1)

verapamil hydrochloride ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "5dfba728-4417-4a75-b194-87feff97aa7b", "openfda": {"unii": ["V3888OEY5R"], "rxcui": ["897649"], "spl_set_id": ["c635f442-2349-4820-877a-a42e5f0a44b5"], "manufacturer_name": ["Aphena Pharma Solutions - Tennessee, LLC"]}, "finished": true, "packaging": [{"sample": false, "description": "90 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (71610-268-60)", "package_ndc": "71610-268-60", "marketing_start_date": "20190501"}], "brand_name": "verapamil hydrochloride", "product_id": "71610-268_5dfba728-4417-4a75-b194-87feff97aa7b", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "71610-268", "generic_name": "verapamil hydrochloride", "labeler_name": "Aphena Pharma Solutions - Tennessee, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "verapamil hydrochloride", "active_ingredients": [{"name": "VERAPAMIL HYDROCHLORIDE", "strength": "240 mg/1"}], "application_number": "ANDA078906", "marketing_category": "ANDA", "marketing_start_date": "20090917", "listing_expiration_date": "20261231"}